English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Synthetic glycans control gut microbiome structure and mitigate colitis in mice

Tolonen, A. C., Beauchemin, N., Bayne, C., Li, L., Tan, J., Lee, J., et al. (2022). Synthetic glycans control gut microbiome structure and mitigate colitis in mice. Nature Communications, 13(1): 1244. doi:10.1038/s41467-022-28856-x.

Item is

Basic

show hide
Genre: Journal Article

Files

show Files
hide Files
:
rapp_3377632.pdf (Publisher version), 3MB
Name:
rapp_3377632.pdf
Description:
-
Visibility:
Public
MIME-Type / Checksum:
application/pdf / [MD5]
Technical Metadata:
Copyright Date:
-
Copyright Info:
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder .

Locators

show

Creators

show
hide
 Creators:
Tolonen, Andrew C.1, Author
Beauchemin, Nicholas1, 2, Author
Bayne, Charlie1, Author
Li, Lingyao1, Author
Tan, Jie1, Author
Lee, Jackson1, Author
Meehan, Brian M.1, 3, Author
Meisner, Jeffrey1, Author
Millet, Yves1, Author
LeBlanc, Gabrielle1, Author
Kottler, Robert4, Author
Rapp, Erdmann4, 5, Author              
Murphy, Chris6, Author
Turnbaugh, Peter J.7, Author
von Maltzahn, Geoffrey1, 8, Author
Liu, Christopher M.1, 9, Author
van Hylckama Vlieg, Johan E. T.1, Author
Affiliations:
1Kaleido Biosciences, Lexington, MA, USA , ou_persistent22              
2Seres Therapeutics, Cambridge, MA, USA, ou_persistent22              
3Pareto Bio, Cambridge, MA, USA, ou_persistent22              
4glyXera GmbH, Magdeburg, Germany, ou_persistent22              
5Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society, ou_1738140              
6Bacainn Therapeutics, Inc and Morningside BioPharma Advisory, Concord, MA, USA, ou_persistent22              
7Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA, ou_persistent22              
8Flagship Pioneering, Cambridge, MA, USA, ou_persistent22              
9Exo Therapeutics, Watertown, MA, USA, ou_persistent22              

Content

show

Details

show
hide
Language(s): eng - English
 Dates: 2022
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: DOI: 10.1038/s41467-022-28856-x
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Nature Communications
  Abbreviation : Nat. Commun.
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: London : Nature Publishing Group
Pages: - Volume / Issue: 13 (1) Sequence Number: 1244 Start / End Page: - Identifier: ISSN: 2041-1723
CoNE: https://pure.mpg.de/cone/journals/resource/2041-1723